Gronghui Sept. 8 | 300341.SZ once again rose more than 7% to 12 yuan and rebounded to a high price, with a cumulative increase of 25% after the performance, with a total market capitalization of 6.2 billion yuan. Medium-term revenue and net profit reported at the end of August fell, but share prices continued to rebound from their lows. In addition, Mike Audi and Varian Healthcare recently signed a letter of intent for a strategic cooperation framework focusing on full-cycle cancer management.
A股异动 | 麦克奥迪涨超7%创反弹新高 绩后累涨25%
Changes in A-shares | McAudie rose more than 7%, rebounded and achieved new high results, then rose 25%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.